The complex role of AIM2 in the tumor microenvironment may be more complicated through its inhibition of several signaling pathways including AKT (16) as well as STING-type 1 interferon signaling (7b) Most importantly, how AIM2 gets activated in cancer remains unknown. The gene discussed is AKT1; the disease is neoplasm.